Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CY2Z
|
|||
| Former ID |
DIB005004
|
|||
| Drug Name |
HuMax-HepC
|
|||
| Synonyms |
E2-hmAb; HCV-specific antibody, Genmab; Hepatitis C virus-specific antibody, Connex/INSERM
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Terminated | [1] | |
| Company |
Genmab A/S
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis C virus Envelope glycoprotein E2 (HCV NS1) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019390) | |||
| REF 2 | Clinical pipeline report, company report or official report of Genmab. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.